Intervention Review

Cyclophosphamide for multiple sclerosis

  1. Loredana La Mantia1,*,
  2. Clara Milanese1,
  3. Nerina Mascoli1,
  4. Roberto D'Amico2,
  5. Bianca Weinstock-Guttman3

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 14 NOV 2006

DOI: 10.1002/14651858.CD002819.pub2


How to Cite

La Mantia L, Milanese C, Mascoli N, D'Amico R, Weinstock-Guttman B. Cyclophosphamide for multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002819. DOI: 10.1002/14651858.CD002819.pub2.

Author Information

  1. 1

    Fondazione I.R.C.C.S. - Istituto Neurologico C. Besta, MS Group, Milano, Italy

  2. 2

    University of Modena and Reggio Emilia, Department of Oncology and Hematology, Modena, Italy

  3. 3

    The Jacobs Neurological Institute, State University of New York at Buffalo, Baird MS Center, Buffalo, New York, USA

*Loredana La Mantia, MS Group, Fondazione I.R.C.C.S. - Istituto Neurologico C. Besta, Via Celoria, 11, Milano, 20133, Italy. msgroup@istituto-besta.it.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.